Sep 30, 2022

Enliven Therapeutics Q3 2022 Earnings Report

EPS
-$0.72
Previous year: -$2.2
-67.3%
Cash and Equivalents
$86.2M
Previous year: $103M
-16.2%
Total Assets
$59.1M
Previous year: $107M
-44.8%

Enliven Therapeutics

Enliven Therapeutics